81 related articles for article (PubMed ID: 30217302)
1. Nephrotoxicity and long-term survival investigations for patients with peritoneal carcinomatosis using hyperthermic intraperitoneal chemotherapy with cisplatin: A retrospective cohort study.
Ye J; Ren Y; Wei Z; Peng J; Chen C; Song W; Tan M; He Y; Yuan Y
Surg Oncol; 2018 Sep; 27(3):456-461. PubMed ID: 30217302
[TBL] [Abstract][Full Text] [Related]
2. Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy in gastric cancer.
Seshadri RA; Glehen O
World J Gastroenterol; 2016 Jan; 22(3):1114-30. PubMed ID: 26811651
[TBL] [Abstract][Full Text] [Related]
3. Neoadjuvant chemotherapy followed by cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for colorectal cancer: a feasibility and safety study.
Leimkühler M; Hemmer PHJ; Reyners AKL; de Groot DJA; van Ginkel RJ; Been LB; de Bock GH; van Leeuwen BL
World J Surg Oncol; 2019 Jan; 17(1):14. PubMed ID: 30635070
[TBL] [Abstract][Full Text] [Related]
4. Complexity of surgery and treatment burden in patients with peritoneal malignancy is not determined by addition of hyperthermic intraperitoneal chemotherapy.
Steffens D; Ansari N; Koh C; Ahmadi N; Solomon MJ; Hogan S; Karunaratne S; Anderson T; Harvey K; McBride K; Moran B
ANZ J Surg; 2024 Apr; 94(4):628-633. PubMed ID: 38450829
[TBL] [Abstract][Full Text] [Related]
5. Initial Experience Using Laparoscopic HIPEC for Gastric Cancer with Peritoneal Metastasis: Safety and Outcomes.
Read MD; Drake J; Hashemipour G; Powers BD; Mehta R; Sinnamon A; Pimiento JM; Dineen SP
Ann Surg Oncol; 2024 Jun; 31(6):3750-3757. PubMed ID: 38430428
[TBL] [Abstract][Full Text] [Related]
6. Improved Postoperative Pain Management Outcomes After Implementation of Enhanced Recovery After Surgery (ERAS) Protocol for Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy (CRS-HIPEC).
Yue TM; Sun BJ; Xu N; Ohkuma R; Fowler C; Lee B
Ann Surg Oncol; 2024 Jun; 31(6):3769-3777. PubMed ID: 38466484
[TBL] [Abstract][Full Text] [Related]
7. Postoperative C-reactive protein kinetics predict postoperative complications in patients treated with cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for peritoneal carcinomatosis.
Asmar AE; Bendavides M; Moreau M; Hendlisz A; Deleporte A; Khalife M; Donckier V; Liberale G
World J Surg Oncol; 2020 Nov; 18(1):311. PubMed ID: 33243287
[TBL] [Abstract][Full Text] [Related]
8. Does Hospital Operative Volume Influence the Outcomes of Patients After Heated Intraperitoneal Chemotherapy for Peritoneal Carcinomatosis?
Chatani PD; Manzella A; Gribkova YY; Ecker BL; Beninato T; Kennedy T; Pitt HA; Alexander HR
Ann Surg Oncol; 2024 Feb; 31(2):1049-1057. PubMed ID: 37906385
[TBL] [Abstract][Full Text] [Related]
9. Development of a predictive model for risk stratification of acute kidney injury in patients undergoing cytoreductive surgery with hyperthermic intraperitoneal chemotherapy.
Krause M; Mehdipour S; Veerapong J; Baumgartner JM; Lowy AM; Gabriel RA
Sci Rep; 2024 Mar; 14(1):6630. PubMed ID: 38503776
[TBL] [Abstract][Full Text] [Related]
10. Impact of hyperthermic intraperitoneal chemotherapy on Hsp27 protein expression in serum of patients with peritoneal carcinomatosis.
Kepenekian V; Aloy MT; Magné N; Passot G; Armandy E; Decullier E; Sayag-Beaujard A; Gilly FN; Glehen O; Rodriguez-Lafrasse C
Cell Stress Chaperones; 2013 Sep; 18(5):623-30. PubMed ID: 23508575
[TBL] [Abstract][Full Text] [Related]
11. Negative Pressure Wound Therapy to Reduce Surgical Site Infections after CRS/HIPEC.
Nabata KJ; Rai S; Zhao D; MacNeill AJ; Hamilton TD
Ann Surg Oncol; 2024 Jul; 31(7):4735-4740. PubMed ID: 38653941
[TBL] [Abstract][Full Text] [Related]
12. Continuous Wound Irrigation and Intraoperative Methadone Decreases Opioid Use and Shortens Length of Stay After CRS/HIPEC.
Boesl MA; Brown N; Bleicher J; Call T; Lambert DH; Lambert LA
Ann Surg Oncol; 2024 Jun; 31(6):3742-3749. PubMed ID: 38300404
[TBL] [Abstract][Full Text] [Related]
13. Incidence, risk factors, and outcomes of the transition of HIPEC-induced acute kidney injury to acute kidney disease: a retrospective study.
Lu Y; Xiao Z; Zhao X; Ye Y; Li S; Guo F; Xue H; Zhu F
Ren Fail; 2024 Dec; 46(1):2338482. PubMed ID: 38604946
[TBL] [Abstract][Full Text] [Related]
14. Cisplatin exhibits superiority over MMC as a perfusion agent in a peritoneal mesothelioma patient specific organoid HIPEC platform.
Forsythe SD; Erali RA; Edenhoffer N; Meeker W; Wajih N; Schaaf CR; Laney P; Vanezuela CD; Li W; Levine EA; Soker S; Votanopoulos KI
Sci Rep; 2023 Jul; 13(1):11640. PubMed ID: 37468581
[TBL] [Abstract][Full Text] [Related]
15. Peritoneal Mesothelioma: Systematic Review of Hyperthermic Intraperitoneal Chemotherapy (HIPEC) Protocol Outcomes.
Kepenekian V; Sgarbura O; Marchal F; Villeneuve L; Glehen O; Kusamura S; Deraco M
Indian J Surg Oncol; 2023 Jun; 14(Suppl 1):39-59. PubMed ID: 37359920
[TBL] [Abstract][Full Text] [Related]
16. Nanovehicles as a novel target strategy for hyperthermic intraperitoneal chemotherapy: a multidisciplinary study of peritoneal carcinomatosis.
Nowacki M; Wisniewski M; Werengowska-Ciecwierz K; Roszek K; Czarnecka J; Łakomska I; Kloskowski T; Tyloch D; Debski R; Pietkun K; Pokrywczynska M; Grzanka D; Czajkowski R; Drewa G; Jundziłł A; Agyin JK; Habib SL; Terzyk AP; Drewa T
Oncotarget; 2015 Sep; 6(26):22776-98. PubMed ID: 26254295
[TBL] [Abstract][Full Text] [Related]
17. The safety and effectiveness of prophylactic hyperthermic intraperitoneal chemotherapy in patients with pathological T3-4 locally advanced colon cancer.
Mo T; Wen X; Hu T; Zhang Z; Shi Y; Chen Y; Xiang H; Huang J; Xian Z; He X
Asian J Surg; 2024 Apr; ():. PubMed ID: 38604861
[TBL] [Abstract][Full Text] [Related]
18. A case report of acute pulmonary hypertension after hyperthermic intraperitoneal chemotherapy (HIPEC) and review of the literature.
Zajonz TS; Sander M; Padberg W; Hecker A; Hörbelt R; Koch C; Schneck E
Ann Med Surg (Lond); 2018 Mar; 27():26-31. PubMed ID: 29511539
[TBL] [Abstract][Full Text] [Related]
19. Refractory Hypotension and Rapid Onset AKI: Deadly Complication After Doxorubicin and Mitomycin-C HIPEC Therapy.
Das AK; Sharma A; Kothari N; Choudhary R
Indian J Surg Oncol; 2023 Jun; 14(Suppl 1):189-191. PubMed ID: 37359929
[No Abstract] [Full Text] [Related]
20. Single institution best recommendation is HIPEC with cisplatin and docetaxel.
Sugarbaker PH; Van der Speeten K
J Gastrointest Oncol; 2021 Apr; 12(Suppl 1):S79. PubMed ID: 33970157
[No Abstract] [Full Text] [Related]
[Next] [New Search]
